pfizer glp 1 news Woke up to that just halted their oral GLP-1 candidate after a liver injury was reported in Phase 1. Two thoughts immediately came to mind: 1. This is exactly why Pfizer picks GLP-1 candidate in

26 SarrisJByrneGCastleDBousmanCOliverGCribbLet al

Eli Lilly is likely considering MASLD as a separate indication for regulatory submission, which could accelerate the timeline for liver-specific approval

April 15, 2026: The FDA's updated 503A document removes Epitalon (both Epitalon acetate and Epitalon free base) from Category 2 and schedules a PCAC meeting for July 24, 2026

49,66 Price per portion: 1,66 Buy for 5150 pts You can exchange your accumulated loyalty points for this product

Dai, X., Zhang, R

The formula below is a mathematical representation of Step 4 and adjusts the labor-related portion of the national unadjusted payment rate for the specific service by the wage index